vs

Side-by-side financial comparison of UNIVERSAL TECHNICAL INSTITUTE INC (UTI) and Waystar Holding Corp. (WAY). Click either name above to swap in a different company.

Waystar Holding Corp. is the larger business by last-quarter revenue ($313.9M vs $221.4M, roughly 1.4× UNIVERSAL TECHNICAL INSTITUTE INC). Waystar Holding Corp. runs the higher net margin — 13.8% vs 0.2%, a 13.6% gap on every dollar of revenue. On growth, Waystar Holding Corp. posted the faster year-over-year revenue change (22.4% vs 6.7%). Over the past eight quarters, Waystar Holding Corp.'s revenue compounded faster (15.7% CAGR vs 11.7%).

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

Waystar Holding Corp is a leading provider of integrated healthcare payment and revenue cycle management solutions. It serves healthcare providers, health systems, and payers across the United States, offering tools that streamline billing, claims processing, patient payment collection, and revenue optimization to reduce administrative burdens and improve financial performance for healthcare organizations.

UTI vs WAY — Head-to-Head

Bigger by revenue
WAY
WAY
1.4× larger
WAY
$313.9M
$221.4M
UTI
Growing faster (revenue YoY)
WAY
WAY
+15.7% gap
WAY
22.4%
6.7%
UTI
Higher net margin
WAY
WAY
13.6% more per $
WAY
13.8%
0.2%
UTI
Faster 2-yr revenue CAGR
WAY
WAY
Annualised
WAY
15.7%
11.7%
UTI

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
UTI
UTI
WAY
WAY
Revenue
$221.4M
$313.9M
Net Profit
$433.0K
$43.3M
Gross Margin
Operating Margin
0.2%
25.6%
Net Margin
0.2%
13.8%
Revenue YoY
6.7%
22.4%
Net Profit YoY
-60.5%
47.9%
EPS (diluted)
$0.01
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
UTI
UTI
WAY
WAY
Q1 26
$221.4M
$313.9M
Q4 25
$220.8M
$303.5M
Q3 25
$222.4M
$268.7M
Q2 25
$204.3M
$270.7M
Q1 25
$207.4M
$256.4M
Q4 24
$201.4M
$244.1M
Q3 24
$196.4M
$240.1M
Q2 24
$177.5M
$234.5M
Net Profit
UTI
UTI
WAY
WAY
Q1 26
$433.0K
$43.3M
Q4 25
$12.8M
$20.0M
Q3 25
$18.8M
$30.6M
Q2 25
$10.7M
$32.2M
Q1 25
$11.4M
$29.3M
Q4 24
$22.2M
$19.1M
Q3 24
$18.8M
$5.4M
Q2 24
$5.0M
$-27.7M
Operating Margin
UTI
UTI
WAY
WAY
Q1 26
0.2%
25.6%
Q4 25
7.1%
19.4%
Q3 25
11.2%
22.4%
Q2 25
6.9%
24.0%
Q1 25
8.1%
25.4%
Q4 24
13.6%
21.8%
Q3 24
13.3%
11.3%
Q2 24
4.2%
3.5%
Net Margin
UTI
UTI
WAY
WAY
Q1 26
0.2%
13.8%
Q4 25
5.8%
6.6%
Q3 25
8.4%
11.4%
Q2 25
5.2%
11.9%
Q1 25
5.5%
11.4%
Q4 24
11.0%
7.8%
Q3 24
9.6%
2.3%
Q2 24
2.8%
-11.8%
EPS (diluted)
UTI
UTI
WAY
WAY
Q1 26
$0.01
$0.42
Q4 25
$0.23
$0.10
Q3 25
$0.33
$0.17
Q2 25
$0.19
$0.18
Q1 25
$0.21
$0.16
Q4 24
$0.40
$0.18
Q3 24
$0.35
$0.03
Q2 24
$0.09
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
UTI
UTI
WAY
WAY
Cash + ST InvestmentsLiquidity on hand
$162.0M
$34.3M
Total DebtLower is stronger
$127.8M
$13.5M
Stockholders' EquityBook value
$339.9M
$3.9B
Total Assets
$852.2M
$5.8B
Debt / EquityLower = less leverage
0.38×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
UTI
UTI
WAY
WAY
Q1 26
$162.0M
$34.3M
Q4 25
$162.8M
$61.4M
Q3 25
$169.1M
$421.1M
Q2 25
$70.7M
$290.3M
Q1 25
$96.0M
$224.0M
Q4 24
$172.0M
$182.1M
Q3 24
$161.9M
$127.1M
Q2 24
$115.5M
$68.4M
Total Debt
UTI
UTI
WAY
WAY
Q1 26
$127.8M
$13.5M
Q4 25
$101.4M
$1.5B
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
$1.2B
Q3 24
$125.7M
Q2 24
$137.3M
Stockholders' Equity
UTI
UTI
WAY
WAY
Q1 26
$339.9M
$3.9B
Q4 25
$335.9M
$3.9B
Q3 25
$328.1M
$3.2B
Q2 25
$306.8M
$3.2B
Q1 25
$293.9M
$3.1B
Q4 24
$280.0M
$3.1B
Q3 24
$260.2M
$3.1B
Q2 24
$239.4M
$2.9B
Total Assets
UTI
UTI
WAY
WAY
Q1 26
$852.2M
$5.8B
Q4 25
$834.0M
$5.8B
Q3 25
$826.1M
$4.7B
Q2 25
$740.8M
$4.7B
Q1 25
$720.4M
$4.6B
Q4 24
$753.8M
$4.6B
Q3 24
$744.6M
$4.5B
Q2 24
$706.0M
$4.6B
Debt / Equity
UTI
UTI
WAY
WAY
Q1 26
0.38×
0.00×
Q4 25
0.30×
0.38×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
0.40×
Q3 24
0.48×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
UTI
UTI
WAY
WAY
Operating Cash FlowLast quarter
$7.1M
$84.9M
Free Cash FlowOCF − Capex
$90.3M
FCF MarginFCF / Revenue
28.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
16.33×
1.96×
TTM Free Cash FlowTrailing 4 quarters
$314.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
UTI
UTI
WAY
WAY
Q1 26
$7.1M
$84.9M
Q4 25
$3.1M
$66.6M
Q3 25
$57.1M
$82.0M
Q2 25
$18.1M
$96.8M
Q1 25
$-789.0K
$64.2M
Q4 24
$23.0M
Q3 24
$67.5M
$78.8M
Q2 24
$10.0M
$15.4M
Free Cash Flow
UTI
UTI
WAY
WAY
Q1 26
$90.3M
Q4 25
$-19.2M
$57.2M
Q3 25
$40.6M
$76.2M
Q2 25
$6.8M
$91.0M
Q1 25
$-11.7M
$58.8M
Q4 24
$19.6M
Q3 24
$60.0M
$70.2M
Q2 24
$3.0M
$8.6M
FCF Margin
UTI
UTI
WAY
WAY
Q1 26
28.8%
Q4 25
-8.7%
18.9%
Q3 25
18.3%
28.3%
Q2 25
3.4%
33.6%
Q1 25
-5.7%
22.9%
Q4 24
9.7%
Q3 24
30.6%
29.2%
Q2 24
1.7%
3.7%
Capex Intensity
UTI
UTI
WAY
WAY
Q1 26
Q4 25
10.1%
3.1%
Q3 25
7.4%
2.2%
Q2 25
5.5%
2.1%
Q1 25
5.3%
2.1%
Q4 24
1.7%
Q3 24
3.8%
3.6%
Q2 24
4.0%
2.9%
Cash Conversion
UTI
UTI
WAY
WAY
Q1 26
16.33×
1.96×
Q4 25
0.24×
3.33×
Q3 25
3.04×
2.68×
Q2 25
1.69×
3.01×
Q1 25
-0.07×
2.20×
Q4 24
1.04×
Q3 24
3.58×
14.56×
Q2 24
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

UTI
UTI

Segment breakdown not available.

WAY
WAY

Subscription$172.2M55%
Volume-based$139.5M44%

Related Comparisons